Nanobiotix
NBTX
10 hedge funds and large institutions have $73.2M invested in Nanobiotix in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0.18% less ownership
Funds ownership: 14.78% → 14.6% (-0.18%)
9% less funds holding
Funds holding: 11 → 10 (-1)
10% less capital invested
Capital invested by funds: $81.3M → $73.2M (-$8.12M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$691K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$537K |
| 3 |
Millennium Management
New York
|
-$433K |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$248K |
| 5 |
Morgan Stanley
New York
|
-$192K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $21M | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $15.9M | -$691K | -40,200 | -4% |
|
|
AG
3
Artal Group
Luxembourg
| $15M | – | – | – |
|
|
TCM
4
Tybourne Capital Management
Hong Kong
| $11.3M | – | – | – |
|
|
O
5
OrbiMed
New York
| $7.52M | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $1.05M | +$1.2M | +69,836 | +20,184% |
|
|
WP
7
Woodline Partners
San Francisco,
California
| $970K | -$94.2K | -5,486 | -8% |
|
|
8
Millennium Management
New York
| $332K | -$433K | -25,179 | -53% |
|
|
9
Morgan Stanley
New York
| $5K | -$192K | -11,190 | -97% |
|
|
AWM
10
Activest Wealth Management
Aventure,
Florida
| $4K | +$4.86K | +283 | New |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$537K | -32,556 | Closed |
|
|
MIM
12
Monashee Investment Management
Boston,
Massachusetts
| – | -$248K | -15,000 | Closed |
|
NBTX Hedge Fund Activity: Q1 2021 in Review
10 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q1 2021, worth a combined $73.2M — down 10% from $81.3M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NBTX and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $1.2M. The largest seller was Perceptive Advisors, cutting an estimated $691K.
- 10 institutional investors held Nanobiotix (NBTX) as of Q1 2021, down from 11 in Q4 2020.
- Funds reported $73.2M of Nanobiotix stock for Q1 2021, down 10% quarter-over-quarter.
- 1 fund opened new Nanobiotix positions in Q1 2021 and 2 closed out, a net change of -1 holder.
- The largest Nanobiotix buyer in Q1 2021 was UBS Group, an estimated $1.2M added.
- The largest Nanobiotix seller in Q1 2021 was Perceptive Advisors, an estimated $691K sold.
Based on aggregated 13F filings for Q1 2021.